Roche Wins FDA Clearance for New Blood Test to Detect Alzheimer’s Disease
Roche has secured U.S. Food and Drug Administration clearance for Elecsys pTau217, a plasma-based blood test designed to help physicians detect amyloid pathology linked to Alzheimer's...
FDA Grants Approval to Johnson & Johnson’s IMAAVY for Warm Autoimmune Hemolytic Anemia
Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved IMAAVY® (nipocalimab-aahu) as the first therapy specifically indicated for the...
AIIA Rolls Out “Garbhini Mitra” Programme to Widen Community-Level Maternal Support Through Ayurveda
The All India Institute of Ayurveda (AIIA) in New Delhi, an autonomous body under the Ministry of Ayush, has launched a new skill-development course called Garbhini Mitra for...
GSK’s Hibsago Becomes World’s First Approved Functional Cure for Chronic Hepatitis B
GSK has secured its first global regulatory approval for Hibsago(bepirovirsen), marking the debut of a functional cure option for chronic hepatitis B (CHB) anywhere in...
Fortis Healthcare Launches Lung Failure Clinics in New Delhi to Enhance Advanced Respiratory and Transplant Care
Fortis Healthcare has announced the launch of dedicated Lung Failure Clinics at its Shalimar Bagh and Vasant Kunj facilities in New Delhi. The initiative establishes a specialized, multidisciplinary...
Symbiotec Pharmalab Announces ₹1,757 Crore IPO to Fuel Biopharma Growth
Symbiotec Pharmalab, a leading research and development-driven pharmaceutical and biotechnology player, has announced details of its ₹1,757 crore Initial Public Offering (IPO). The public issue...
